Fig. 3From: A review of literature on Compound 21-loaded gelatin nanoparticle: a promising nose-to-brain therapy for multi-infarct dementiaAT2R pathway in neural protection. AT2R: angiotensin II receptor type 2, MMS2: methyl methane sulfonate 2, NO: nitric oxide, SHP-1: anti-Src homology phosphatase-1, sensitive 2, Ubc13: ubiquitin-conjugating enzyme 13Back to article page